Find your next paid study

Children's Oncology GroupNCT03067181

~$50 – $2,250

Actual pay is set by the research site.

Phase 2

A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy

The purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with r…

Squamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more

Memorial Sloan Kettering Cancer CenterNCT07063212

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

Randomized Phase 2 Trial of Ruxolitinib in Combination With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma.

The purpose of this research is to test the safety and effectiveness of the investigational drug ruxolitinib when it is combined with standard of care treatmen…

GlioblastomaBrain CancerGlioblastoma Multiforme+4 more

Baptist Health South FloridaNCT06991101

~$75 – $3,000

Actual pay is set by the research site.

Female Reproductive System Adnexal NeoplasmOvarian CarcinomaFemale Reproductive System Neoplasm+3 more

Ultrasound Imaging of Ovarian and Adnexal Lesions

This clinical trial studies how well ultrasound microvessel imaging (UMI) works in evaluating ovarian and adnexal lesions in patients who are scheduled to have…

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07280312

Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…

OncologyMEK MutationRAF Gene Mutation+6 more

A Phase I, Open Label Single-arm Two-part Study to Investigate Safety, Pharmacokinetics, and Preliminary Efficacy of Pan-RAF/MEK Glue NST-628 Oral Tablets in Subject With Solid Tumors Harboring Genetic Alterations in the MAPK Pathway and With Other Solid Tumors

This is a two-part Phase 1, open label, multi-center, single arm, non-randomized, multiple dose, safety, pharmacokinetic (PK) and preliminary efficacy study of…

Nested Therapeutics, IncNCT06326411

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ENV-294 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

The goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis. The main questi…

Atopic Dermatitis (AD)

Enveda TherapeuticsNCT07298395

~$75 – $2,800

Actual pay is set by the research site.

Sickle Cell DiseaseAdverse Childhood ExperiencesBreastfeeding

Early Life Exposures Among Children With Sickle Cell Disease

This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of He…

University of Alabama at BirminghamNCT05377372

~$10 – $750

Actual pay is set by the research site.

Pancreatic Adenocarcinoma

A Phase 1, Prospective, Standard Dose Escalation Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

The purpose of this study is to determine whether a new treatment combining radiation therapy with PCX12 is safe and tolerable.

Haoming (Carl) QiuNCT06217666

~$150 – $4,500

Actual pay is set by the research site.

Behavioral and Neural Target Engagement for ADHD Executive Working Memory Training

The proposed study will replicate target engagement as assessed in the first phase while also determining if it correlates with clinically meaningful improveme…

ADHD

Hartford HospitalNCT06446284

~$10 – $750

Actual pay is set by the research site.

Ovarian CancerBreast CancerEndometrial Cancer+3 more

A Phase 1, Open-label, Dose Escalation and Dose Expansion Study for LNCB74, a B7-H4 Targeted Antibody Drug Conjugate, as Monotherapy in Participants With Advanced Solid Tumors

This is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and …

NextCure, Inc.NCT06774963

~$150 – $4,200

Actual pay is set by the research site.

Older Adults Without Any Specific Clinical ConditionSocial NetworksRSV Immunization+1 more

Motivate Vaccinate Activate: An Effectiveness-Implementation Trial to Assess the Impact of a Multi-Component Community-Based Intervention to Increase RSV Vaccine Uptake Among Latino Older Adults

In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective …